Q2 Earnings Wave Splits Market: Medtech and Fintech Beat as Consumer Names Retrench

The earnings tape delivered an unusually clean read on where operating leverage still exists. In medtech, Natera reported a 57.2% jump in oncology volumes on molecular residual disease adoption, iRhythm grew revenue 20% with simultaneous margin expansion and a full-year guidance raise, and ICU Medical set a record in Infusion Systems on 12% organic growth in pumps. Concentra added rate-driven margin expansion on higher patient visits. In financials, Nu Holdings crossed the $1 billion quarterly profit threshold with a risk-adjusted margin of 12.4%, while StepStone booked a record $40 billion of annual AUM additions as its Private Wealth platform scales. Twilio's $1.50 billion revenue print with accelerating gross profit and record free cash flow reinforced the software-profitability rotation. The other side of the ledger is where the caution lies. Post saw pet food volumes contract 7.8% as management prioritized deleveraging over volume defense; i3 Verticals grew ARR 8.3% but guided down as professional services delays offset SaaS momentum; and Dragonfly Energy is repositioning toward trucking as RV demand softens. Amrize flagged oil-linked input inflation compressing margins even as data center construction lifted cement and roofing volumes — a reminder that AI-adjacent demand is not a universal margin cure. For allocators, the message is dispersion: revenue growth is available, but the market is increasingly paying only for growth that converts to cash.